Researchers at Stanford have developed methods to link antigenic or immunomodulatory molecules to bacterial surface proteins of commensal bacteria that result in a high immune response when applied to an epithelial surface of a mammal.
Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Researchers at Stanford have developed a nanoparticle-based platform to enhance activation of self-specific CD8+ T cells in the tumor microenvironment to fight cancer while minimizing toxic side effects.
Stanford researchers within the Dionne Lab have developed a method to use copper titanium dioxide core-shell nanoparticles for the light driven production of green fuels or removal of contaminants in water.
Stanford inventors have developed a nanoparticle containing the toll-like receptor agonist (TLR7-NP) that elicits a potent anti-tumor immune response in multiple cancer types without inducing undesired systemic inflammation and toxicity.
Stanford researchers have developed a nanoparticle adjuvant with spatiotemporal controlled release of TLR7 agonist for broad protection against influenza or SARS-CoV-2.
This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.
Stanford scientists have invented a new PET-nanophotonic metamaterial scintillator that consists of tunable scintillating alkaline-earth rare-earth fluoride nanoparticles (MLnF) for low-dose, high-resolution PET imaging.
Stanford researchers have developed a method to eliminate antibiotic resistant gram-negative bacteria in the growth arrest phase. The increase in relapsing bacterial infections and the rise of drug resistant bacteria are significant global health problems.
To combat the growing problem of antibiotic resistant bacteria, Stanford researchers have developed nanoclusters comprising a metallic core conjugated to a nucleotide.
Stanford researchers have developed a novel approach to make a stable and active platinum-alumina catalyst that maintains high activity under harsh conditions.
Stanford researchers have designed a light-driven bimetallic alloyed plasmonic photocatalyst that can both effectively and selectively catalyze heterogenous hydrogenation.
Stanford researchers have discovered a new class of metallic glass alloys with superior properties such as low cost, high wear resistance, and electric conductivity comparable to graphite.